Characterization of in vivo assembled SEC purified capsids by SDS-PAGE showed two bands corresponding to CP (~47 kDa) and StAv-SP (~35 kDa) confirming the encapsulation of StAv ( Figure S1A ). The capsids were subsequently analyzed by SEC-MALS/QELS ( Figure S1B ). SEC-MALS revealed an average molecular weight of 31.6 ± 0.2 MDa, which corresponds to a loading of approximately 338 copies of StAv subunits. The size of the particles, determined by MALS and QELS (R g = 26.4 ± 0.3 nm) (R h = 27.9 ± 0.1 nm) matched with those previously reported for encapsulated P22 materials. Transmission electron microscopy (TEM) confirmed that encapsulation did not alter the cage architecture, and that the size of assembled P22-StAv particles (R= 26.5 ± 1.3 nm) were consistent with T=7 P22 particles ( Figure S1C ). Binding activity of encapsulated StAv was assayed by cumulative titration of StAv with Biotin-4-fluorescein (B4F). The binding of B4F to StAv accompanies with a significant change in molar extinction coefficient of B4F at 493 nm, resulting which a decreased absorbance at that wavelength is observed. 1 Commercial streptavidin was titrated as positive control and PBS was used as negative control. With PBS, the absorbance was increased linearly with a constant slope throughout the successive additions of B4F, whereas in commercial StAv, reduction in absorbance was observed until all binding sites became saturated with B4F. Further addition of B4F resulted in an increase in absorbance with a slope similar to the control experiment, indicating absence of non-specific binding. The data was plotted between absorbance and molar ratio of [B4F]/[StAv subunit] and fitted with a user-defined piecewise linear regression function in Igor pro 6.37. The breakpoint at molar ratio of [B4F]/[StAv subunit] = 1 indicated the binding stoichiometry of StAv to B4F, and that all sites are functional, and in agreement with the specifications provided by the vendor. To measure binding activity of the StAv in P22-StAv, the concentration of encapsulated StAv was calculated from the absorbance at 280 nm using a molar extinction coefficient of 215, 000 M -1 cm -1 . Details on the determination of molar extinction coefficient is provided later in supplementary information.
Purification and characterization of in vivo assembled P22-StAv
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Calculation for determining concentration of StAv in P22
The concentration of StAv in P22 VLPs was calculated using molar mass provided by SEC-MALS.
To get the number of StAv copies encapsulated in the P22 VLPs, the molar mass of empty coat protein shell (19.7 MDa) was subtracted from the molar mass of P22-StAv (31.6 MDa). The mass obtained was then divided by the theoretical molecular weight of StAv-SP, to give 338 copies of streptavidin per capsid. Using the number of copies and A280, the concentration of StAv was calculated as follows:
The total absorbance from P22-StAv can be written as follows 
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where A T is the total absorbance, A CP is the absorbance contribution from CP, and A StAv-SP is the absorbance from StAv-SP. According to the Lambert-beer's law In this equation, both extinction coefficients are known (calculated from expasy), the path length is known, and A T is measured, leaving only C StAv-SP . From equation 4 the concentration of StAv-SP was calculated under denatured conditions. The concentration calculated under denatured condition was used to calculate the extinction coefficient of the capsid containing 338 copies of streptavidin under non-denaturing condition. The extinction coefficient obtained was 215,000 M -1 cm -1 . This extinction was used to calculate the concentration of streptavidin for each sample used from the same capsid batch. The extinction coefficient was calculated for every batch of P22-StAv prepared fresh, using the above protocol.
Nucleotide and amino acid sequences
6xhis-StAv 15-159 -GAAG-ENLYFQS-GAAG-SP 142-303 (StAv-SP) Nucleotide sequence ATG GGT CAT CAT CAT CAT CAT CAT GCC GGC ATC ACC GGC ACC TGG TAC AAC CAG CTC GGC TCG ACC TTC ATC GTG ACC GCG GGC GCC GAC GGC GCC CTG ACC GGA ACC TAC GAG TCG GCC GTC GGC AAC GCC GAG AGC CGC TAC GTC CTG ACC GGT CGT TAC GAC AGC GCC CCG GCC ACC GAC GGC AGC GGC ACC GCC CTC GGT TGG ACG GTG GCC TGG AAG AAT AAC TAC CGC AAC GCC CAC TCC GCG ACC ACG TGG AGC GGC CAG TAC GTC GGC GGC GCC GAG GCG AGG ATC AAC ACC CAG TGG CTG CTG ACC TCC GGC ACC ACC GAG GCC AAC GCC TGG AAG TCC ACG CTG GTC GGC CAC GAC ACC TTC ACC AAG GTG AAG CCG TCC GCC GCC TCC ATC GAC GCG GCG AAG AAG GCC GGC GTC AAC AAC GGC AAC CCG CTC GAC GCC GTT CAG CAG GGT GCA GCA GGT GAA AAC CTG TAT TTC CAG AGC GGT GCG GCA GGC CGC AGC AAT GCC GTA GCA GAA CAG GGC CGC AAG ACT CAG GAG TTT ACC CAG CAA TCA GCG CAA TAC GTC GAA GCT GCC CGC AAA CAC TAT GAC GCG GCG GAA AAG CTC AAC ATC CCT GAC TAT CAG GAG AAA GAA GAC GCA TTT ATG CAA CTG GTT CCG CCT GCG GTT GGG GCC GAC ATT ATG CGC CTG TTC CCG GAA AAG TCC GCC GCG CTC ATG TAT CAC CTG GGG GCA AAC CCG GAG AAA GCC CGC CAG TTA CTG GCG ATG GAT GGG CAG TCC
